Rituximab and Interleukin 2 (IL2) as treatment for CD20+ non-Hodgkin's lymphoma (NHL) following autologous peripheral blood stem cell transplant (ASCT)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 6534-6534 ◽  
Author(s):  
L. A. Holmberg ◽  
D. G. Maloney ◽  
W. I. Bensinger
Sign in / Sign up

Export Citation Format

Share Document